Reaktion #2350913

ord-7779f0bd39f94afbb316e0d932fa8e78

Reaktionsgleichung

CC1CCC(N(C(=O)Nc2ncc(Br)s2)C2CCOCC2)CC1
3-(5-bromo-thiazol-2-yl)-1-(4-methyl-cyclohexyl)-1-(tetrahydro-pyran-4-yl)-urea
CC1CCC(N(C(=O)Nc2ncc(Br)s2)C2CCOCC2)CC1
3-(5-Bromo-thiazol-2-yl)-1-(4-methyl-cyclohexyl)-1-(tetrahydro-pyran-4-yl)-urea
COC(=O)CS
methyl thioglycolate
→
COC(=O)CSc1cnc(NC(=O)N(C2CCOCC2)C2CCC(C)CC2)s1
{2-[3-(4-Methyl-cyclohexyl)-3-(tetrahydro-pyran-4-yl)-ureido]-thiazol-5-ylsulfanyl}-acetic acid methyl ester

Edukte

CC1CCC(N(C(=O)Nc2ncc(Br)s2)C2CCOCC2)CC1
3-(5-bromo-thiazol-2-yl)-1-(4-methyl-cyclohexyl)-1-(tetrahydro-pyran-4-yl)-urea
CC1CCC(N(C(=O)Nc2ncc(Br)s2)C2CCOCC2)CC1
3-(5-Bromo-thiazol-2-yl)-1-(4-methyl-cyclohexyl)-1-(tetrahydro-pyran-4-yl)-urea
COC(=O)CS
methyl thioglycolate

Reagenzien

Keine

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    SonstigePrepared

Vorschrift

Prepared as described in general procedure (D) using 3-(5-bromo-thiazol-2-yl)-1-(4-methyl-cyclohexyl)-1-(tetrahydro-pyran-4-yl)-urea (Example 203) and methyl thioglycolate.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US07851636B2uspto-grants-2010_12